INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

1,209 studies · page 7 of 51

2013 / Meta-analysis of prospective studies

Higher total cholesterol was associated with lower risk of hemorrhagic stroke.

A meta-analysis examined 23 prospective studies including 1,430,141 participants and 7,960 hemorrhagic strokes. Higher total cholesterol was associated with lower risk of hemorrhagic stroke (RR 0.69, 95% CI 0.59-0.81), as was low-density lipoprotein cholesterol (RR 0.62, 95% CI 0.41-0.92). In contrast, high-density lipoprotein cholesterol was positively linked to intracerebral hemorrhage risk (RR 1.17, 95% CI 1.02-1.35).

Shows an association, not proof of cause and effect.

Wang X, Dong Y, Qi X, et al. Stroke, 2013. PMID 23704101

2013 / Meta-analysis of observational studies

Adherence to a Mediterranean diet was linked to reduced risk of brain disorders.

A meta-analysis pooled findings from 22 studies evaluating adherence to a Mediterranean dietary pattern. Greater adherence was associated with reduced risk of stroke (RR 0.71, 95% CI 0.57-0.89), depression (RR 0.68, 95% CI 0.54-0.86), and cognitive impairment (RR 0.60, 95% CI 0.43-0.83). Moderate adherence was also linked to lower risk of depression and cognitive decline.

Shows an association, not proof of cause and effect.

NANO counterpoint →

Psaltopoulou T, Sergentanis TN, Panagiotakos DB, et al. Ann Neurol, 2013. PMID 23720230

2013 / Systematic review and meta-analysis of epidemiological studies

Pesticide exposure was linked to an increased risk of Parkinson's disease in a meta-analysis of epidemiological studies.

A systematic review and meta-analysis assessed epidemiological studies evaluating pesticide exposure and Parkinson's disease (PD). Summary effect sizes (ES) showed a positive association between PD and overall pesticide use (ES 1.42; 95% CI 1.32 to 1.52) and occupational pesticide exposure (ES 1.49; 95% CI 1.34-1.66). Both occupational herbicide and insecticide exposures were also significantly associated with PD. The authors noted that most pooled studies were case-control with poor exposure characterization.

Shows an association, not proof of cause and effect.

Allen MT, Levy LS Crit Rev Toxicol, 2013. PMID 23844699

2013 / Meta-analysis of case-control studies

Pesticide-exposed Parkinson disease patients had higher rates of specific gene mutations

A meta-analysis of ten case-control studies investigated whether pesticide-induced gene mutations relate to Parkinson disease susceptibility. Individuals with Parkinson disease who experienced pesticide exposure had higher gene mutation frequencies compared with healthy controls. Subgroup analyses demonstrated elevated mutation rates specifically within the GSTP1, SLC6A3, and MDR1 genes among exposed patients, with no publication bias observed.

Shows an association, not proof of cause and effect.

Liu X, Ma T, Qu B, et al. Genet Test Mol Biomarkers, 2013. PMID 23987116

2013 / Meta-analysis of prospective studies

Higher dietary and circulating vitamin C levels were associated with lower stroke risk.

A meta-analysis of prospective studies evaluated vitamin C intake, blood levels, and stroke risk. High versus low dietary vitamin C intake was associated with reduced stroke risk (RR 0.81, 95% CI: 0.74 to 0.90; 11 studies), as was higher circulating vitamin C (RR 0.62, 95% CI: 0.49 to 0.79; 6 studies). Vitamin C supplements showed no statistically significant association with stroke (RR 0.83, 95% CI: 0.62 to 1.10; 3 studies).

Shows an association, not proof of cause and effect.

Chen GC, Lu DB, Pang Z, et al. J Am Heart Assoc, 2013. PMID 24284213

2013 / Meta-analysis of randomized controlled trials

Saffron supplementation reduced depressive symptoms compared to placebo in adults with depression.

A meta-analysis of five randomized controlled trials assessed saffron supplementation for major depressive disorder. Saffron significantly reduced depressive symptoms compared with placebo (mean effect size = 1.62, P < 0.001 across 2 trials). Compared with standard antidepressants across 3 trials, saffron showed a null effect size (mean effect size = -0.15), indicating similar efficacy in mitigating depressive symptoms.

Hausenblas HA, Saha D, Dubyak PJ, et al. J Integr Med, 2013. PMID 24299602

2013 / Network meta-analysis of randomised controlled trials

Exercise and drug interventions often showed potentially similar mortality benefits in coronary heart disease, stroke, heart failure, and diabetes prevention.

A network meta-analysis evaluated 305 randomised controlled trials with 339,274 participants across 16 meta-analyses and three recent trials to compare exercise and drug interventions on mortality. No statistically detectable differences were observed between exercise and drug interventions in the secondary prevention of coronary heart disease and prediabetes. For stroke rehabilitation, exercise was more effective than anticoagulants (OR 0.09, 95% CrI 0.01 to 0.70) and antiplatelets (OR 0.10, 95% CrI 0.01 to 0.62), whereas diuretics were more effective than exercise in heart failure (OR 4.11, 95% CrI 1.17 to 24.76).

Naci H, Ioannidis JP BMJ, 2013. PMID 24473061

2012 / Systematic review

Dietary copper, saturated fat, and elevated brain iron linked to Alzheimer's pathology.

A systematic review evaluated 101 studies and reports on copper, iron, and Alzheimer's disease. Eleven interventional trials supplementing or depleting these minerals failed to demonstrate cognitive benefits in patients with Alzheimer's disease. Prospective observational evidence linked cognitive decline to diets simultaneously elevated in copper and saturated fatty acids. Brain iron was elevated in Alzheimer's cases, whereas copper was predominantly unchanged in brain tissue but elevated in serum.

Loef M, Walach H Br J Nutr, 2012. PMID 21767446

2012 / Meta-analysis of randomized controlled trials

Omega-3 fatty acids showed no significant benefit for major depressive disorder.

A meta-analysis evaluated 13 randomized, placebo-controlled trials with 731 participants investigating omega-3 fatty acids for major depressive disorder. Omega-3 treatment demonstrated no significant benefit over placebo for depression severity (SMD = 0.11, 95% CI: -0.04 to 0.26). After adjusting for significant publication bias using the trim-and-fill method, the effect was further diminished (SMD = 0.01, 95% CI: -0.13 to 0.15).

Bloch MH, Hannestad J Mol Psychiatry, 2012. PMID 21931319

2012 / Systematic review and meta-analysis of randomized controlled trials

Homocysteine-lowering B-vitamin supplementation did not improve cognitive performance in randomized trials.

A meta-analysis evaluated 19 randomized, placebo-controlled trials of homocysteine-lowering supplementation with vitamins B6, B12, and folic acid. B-vitamin supplementation did not improve cognitive function in individuals with cognitive impairment (SMD 0.10, 95% CI -0.08 to 0.28) or without cognitive impairment (SMD -0.03, 95% CI -0.1 to 0.04). Findings remained null regardless of study duration, trial sample size, or national folate status.

Ford AH, Almeida OP J Alzheimers Dis, 2012. PMID 22232016

2012 / Systematic review of randomized controlled trials

Ketogenic diets may improve pediatric seizure control, but poor tolerability limits adherence.

A review synthesized four randomized controlled trials involving 289 children and adolescents with epilepsy. The authors reported that available trials suggested the ketogenic regimen yielded short- to medium-term seizure control comparable to antiepileptic drugs. However, long-term adherence was hindered by substantial dropout rates caused by gastrointestinal symptoms and poor palatability. Trials examining adult populations or less restrictive options like the Atkins diet were minimal.

Levy RG, Cooper PN, Giri P Cochrane Database Syst Rev, 2012. PMID 22419282

2012 / Meta-analysis

Alzheimer's disease was linked to higher copper levels in a meta-analysis.

Researchers updated a meta-analysis on copper levels in serum, plasma, and cerebrospinal fluid in Alzheimer's disease. The authors excluded four of five previous studies from their laboratory to limit bias and added two newer serum copper investigations. Across the analyzed studies, patients with Alzheimer's disease demonstrated higher copper concentrations than healthy controls.

Ventriglia M, Bucossi S, Panetta V, et al. J Alzheimers Dis, 2012. PMID 22475798

2012 / Systematic review of randomized controlled trials

Cognitive behavioral therapy for insomnia showed superior long-term effectiveness compared to benzodiazepine and non-benzodiazepine medications.

A systematic review was conducted across multiple databases to identify RCTs comparing cognitive behavioral therapy for insomnia (CBT-I) to prescription or non-prescription medications. Based on 5 included studies, low to moderate grade evidence suggested CBT-I has superior effectiveness to benzodiazepine and non-benzodiazepine drugs in the long term. Conversely, very low grade evidence suggested benzodiazepines were more effective in the short term, and very low grade evidence supported CBT-I for improving psychological outcomes.

Mitchell MD, Gehrman P, Perlis M, et al. BMC Fam Pract, 2012. PMID 22631616

2012 / Meta-analysis of randomized controlled trials

Formula supplemented with long-chain polyunsaturated fatty acids did not improve infant cognition.

A meta-analysis of 12 randomized controlled trials involving 1,802 infants evaluated long-chain polyunsaturated fatty acid supplementation in formula. Supplementation showed no significant effect on early cognitive scores measured by the Bayley Scales of Infant Development. Further subgroup analyses showed that neither fatty acid dosage nor infant prematurity status significantly altered cognitive outcomes.

Qawasmi A, Landeros-Weisenberger A, Leckman JF, et al. Pediatrics, 2012. PMID 22641753

2012 / Systematic review and meta-analysis of randomized controlled trials

Omega-3 supplementation did not improve cognitive function in cognitively healthy older adults.

Three randomized controlled trials evaluated omega-3 fatty acid supplementation for 6 to 40 months in healthy adults aged 60 and older. In two trials with 3,221 participants, Mini-Mental State Examination scores did not differ between omega-3 and placebo groups (MD -0.07, 95% CI -0.25 to 0.10). Tests of word learning, digit span, and verbal fluency in 1,043 participants also showed no benefits, and incident dementia was not evaluated.

Sydenham E, Dangour AD, Lim WS Cochrane Database Syst Rev, 2012. PMID 22696350

2012 / Systematic review and meta-analysis of epidemiological studies

High fluoride exposure was linked to significantly lower IQ scores in children across 27 epidemiological studies.

Researchers conducted a systematic review and meta-analysis of 27 epidemiological studies to evaluate the relationship between increased fluoride exposure and children's neurodevelopment. Using a random-effects model, the standardized weighted mean difference in IQ scores between exposed and reference populations was -0.45 (95% CI: -0.56, -0.35). Subgroup and sensitivity analyses also showed inverse associations, though substantial heterogeneity did not appear to decrease.

Shows an association, not proof of cause and effect.

Choi AL, Sun G, Zhang Y, et al. Environ Health Perspect, 2012. PMID 22820538

2012 / Systematic review of cohort studies

Vegetable but not fruit intake was linked to lower dementia risk.

A systematic review evaluated nine cohort studies with 44,004 participants on fruit and vegetable intake and cognitive decline or dementia. Out of six studies evaluating fruit and vegetables separately, five found that higher vegetable intake was associated with a decreased risk of dementia or cognitive decline. Conversely, evidence was lacking for an association between high fruit intake and reduced risk.

Shows an association, not proof of cause and effect.

Loef M, Walach H J Nutr Health Aging, 2012. PMID 22836704

2012 / Prospective cohort study and meta-analysis

Higher chocolate consumption was associated with a lower risk of stroke in men.

A prospective cohort of 37,103 Swedish men evaluated chocolate intake over 10.2 years, identifying 1,995 incident strokes. Comparing the highest quartile (median 62.9 g/week) to the lowest (median 0 g/week), the relative risk was 0.83 (95% CI 0.70 to 0.99). A meta-analysis of five studies with 4,260 stroke cases showed an overall relative risk of 0.81 (95% CI 0.73 to 0.90) for highest versus lowest consumption.

Shows an association, not proof of cause and effect.

Larsson SC, Virtamo J, Wolk A Neurology, 2012. PMID 22933736

2012 / Meta-analysis of observational studies

Lower omega-3 fatty acid levels were associated with dementia and predementia.

A meta-analysis of 10 observational studies involving 2,280 participants evaluated peripheral blood polyunsaturated fatty acids. Patients with dementia exhibited significantly lower levels of eicosapentaenoic acid (ES = -0.47, P < .0001), docosahexaenoic acid (ES = -0.33, P = .017), and total omega-3 fatty acids (ES = -0.46, P = .001). Patients with predementia syndrome had significantly lower eicosapentaenoic acid levels (ES = -0.44, P = .002), but other polyunsaturated fatty acids showed no significant differences.

Shows an association, not proof of cause and effect.

NANO counterpoint →

Lin PY, Chiu CC, Huang SY, et al. J Clin Psychiatry, 2012. PMID 22938939

2012 / Systematic review and meta-analysis

Family history, constipation, and non-smoking were strongly linked to Parkinson disease diagnosis.

A systematic review and meta-analysis evaluated nonmotor features and potential risk factors for Parkinson disease. The strongest associations with subsequent diagnosis included having a relative with the condition (OR 4.45, 95% CI 3.39-5.83), constipation (RR 2.34, 95% CI 1.55-3.53), and never smoking compared to current smoking (RR 0.44, 95% CI 0.39-0.50). Negative associations were observed for coffee and alcohol consumption, while pesticide exposure and head injury showed positive associations.

Noyce AJ, Bestwick JP, Silveira-Moriyama L, et al. Ann Neurol, 2012. PMID 23071076

2012 / Systematic review and meta-analysis of randomized controlled trials

Evidence remains insufficient to confirm dietary interventions or PUFAs benefit multiple sclerosis.

Six randomized trials evaluated polyunsaturated fatty acids across 794 participants. Supplementation showed no meaningful impact on worsening disability after two years. Linoleic acid intake between 11 and 23 g/day conferred no benefit in 144 patients (RR 1.04, 95% CI 0.66 to 1.63), nor did 2.9 to 3.4 g/day in 65 progressive cases (RR 0.78, 95% CI 0.43 to 1.42). Omega-3 oils also showed no clear benefit in 292 relapsing-remitting participants (RR 0.82, 95% CI 0.65 to 1.03).

Farinotti M, Vacchi L, Simi S, et al. Cochrane Database Syst Rev, 2012. PMID 23235605

2012 / Systematic review and meta-analysis of prospective studies

High dietary glycemic load is associated with higher coronary heart disease and stroke risk

A meta-analysis of 15 prospective studies with 438,073 participants examined dietary glycemic index and glycemic load in relation to cardiovascular outcomes. Higher dietary glycemic load was associated with increased coronary heart disease risk in women (RR=1.49; 95% CI, 1.27-1.73), but not men (RR=1.08; 95% CI, 0.91-1.27), and with stroke (RR=1.19; 95% CI, 1.00-1.43). A linear dose-response was observed, with a 50-unit increase in glycemic load linked to a higher risk of coronary heart disease (RR=1.05; 95% CI, 1.02-1.08).

Shows an association, not proof of cause and effect.

Fan J, Song Y, Wang Y, et al. PLoS One, 2012. PMID 23284926

2011 / Meta-analysis of prospective cohort studies

Physical activity was linked to a lower risk of cognitive decline in nondemented individuals.

A systematic meta-analysis evaluated 15 prospective studies (12 cohorts) including 33,816 nondemented individuals followed for 1 to 12 years, during which 3,210 participants experienced cognitive decline. Using a random-effects model, high physical activity was significantly associated with a 38% lower risk of cognitive decline compared to low activity (HR 0.62, 95% CI 0.54-0.70; P < 0.00001). Low-to-moderate physical activity was also linked to a 35% lower risk of cognitive impairment (HR 0.65, 95% CI 0.57-0.75; P < 0.00001).

Shows an association, not proof of cause and effect.

Sofi F, Valecchi D, Bacci D, et al. J Intern Med, 2011. PMID 20831630

2011 / Meta-analysis of prospective cohort studies

Higher dietary potassium intake was linked to a significantly lower risk of stroke in a meta-analysis of prospective studies.

Researchers performed a meta-analysis of prospective cohort studies published from 1966 to December 2009 with at least 4 years of follow-up to assess habitual potassium intake and cardiovascular outcomes. Across 15 cohort samples involving 247,510 participants, a 1.64-g (42 mmol) per day higher potassium intake was associated with a 21% lower risk of stroke (RR: 0.79; 95% CI: 0.68 to 0.90; p = 0.0007). Trends toward lower risks of CHD and total CVD reached statistical significance in sensitivity analyses after excluding a single cohort (RR: 0.93; 95% CI: 0.87 to 0.99 for CHD, and RR: 0.74; 95% CI: 0.60 to 0.91 for total CVD).

Shows an association, not proof of cause and effect.

D'Elia L, Barba G, Cappuccio FP, et al. J Am Coll Cardiol, 2011. PMID 21371638